NICHD Global Network for Women's and Children's Health
33
2
2
29
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 33 trials
100.0%
+13.5% vs industry average
39%
13 trials in Phase 3/4
14%
4 of 29 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Role: lead
Maternal Newborn Health Registry
Role: lead
Caffeine for Hypoxic Ischemic Encephalopathy
Role: lead
Trial of the Use of Antenatal Corticosteroids in Developing Countries
Role: lead
Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)
Role: lead
Azithromycin-Prevention in Labor Use Study (A-PLUS)
Role: lead
ASPIRIN: Neurodevelopmental Follow-up Trial
Role: lead
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Role: lead
Prevention of Iron Deficiency Anemia Post-delivery
Role: lead
Survey Tool for Screening of Anemia in Women Before Pregnancy
Role: lead
Prevention of Infection in Indian Neonates - Phase II Probiotics Study
Role: lead
Simplified Gestational Age Score
Role: lead
A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
Role: lead
Global Network Implementation of Helping Babies Breathe (HBB)
Role: lead
Chlorhexidine Vaginal and Infant Wash in Pakistan
Role: lead
Verbal Autopsy to Assess Early Neonatal Death and Stillbirth
Role: lead
RCT of Misoprostol for Postpartum Hemorrhage in India
Role: lead
First Breath: Neonatal Resuscitation in Developing Countries
Role: lead
Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo
Role: lead
BRAIN - Home Intervention Trial
Role: lead